Search - tctmd.com

Displaying 1 - 20 of 56

Sort: Relevancy | Date

News Daily News

Aortic Valve Disease Particularly Challenging to Manage Before Age 65: Review

Todd Neale

December 28, 2022

Will Tricuspid Innovation Outpace Mitral? Some Hopes, Some Second-Guessing

Shelley Wood

December 07, 2022

News Daily News

Tricuspid Regurgitation After AF Diagnosis Is Common, Worsens Outcomes

Yael L. Maxwell

December 06, 2022

News Daily News

COAPT Risk Score Useful in Predicting Outcomes in Functional MR

Michael O'Riordan

October 05, 2022

Presentation TCT 2022

Assessment of Technical Success of T-TEER: Knowing When to Stop!

Presenter: Firas Zahr

September 19, 2022

Presentation TCT 2022

Defining the Anatomic and Clinical Boundaries of T-TEER: When Not to Do It!

Presenter: Rebecca Hahn

September 19, 2022

Presentation TCT 2022

TEE Guidance During T-TEER: Imaging Optimization and When to Pull the ICE Catheter!

Presenter: Nadira Hamid

September 19, 2022

Presentation TCT 2022

Clinical Trial Data Supporting the Use of Tricuspid TEER in Symptomatic Severe TR Patients

Presenter: Charles Davidson

September 19, 2022

Presentation TCT 2022

A Left Ventricular Transcatheter Repair Device for HFrEF (Cardiac Success Vsling)

Presenter: Gregg W. Stone

September 19, 2022

Presentation TCT 2022

Combining the Best of Tricuspid Valve Repair & Replacement (CroiValve)

Presenter: Neil P. Fam

September 19, 2022

Presentation TCT 2022

To Repair or Replace: A Treatment Algorithm Derived from Multimodality Imaging

Presenter: Rebecca Hahn

September 17, 2022

News Conference News TCT 2022

TRILUMINATE Pivotal Trial: First Data Support Safety, Efficacy of TriClip

Caitlin E. Cox

September 17, 2022

News Conference News TCT 2022

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

Michael O'Riordan

September 17, 2022

Presentation TCT 2022

REPAIR MR: Expanding the Therapy Options for Moderate Risk DMR Patients with MitraClip

Presenter: Evelio Rodriguez

September 17, 2022

News Daily News

FDA Approves Pascal TEER Device for Degenerative MR

Shelley Wood

September 15, 2022

News Daily News

Radiation Exposure ‘Extraordinarily’ High for Imagers in Structural Procedures

Yael L. Maxwell

July 11, 2022

News Features TVT 2022

Minorities, Poorer Patients Missing Out on Structural Heart Care

Michael O'Riordan

June 15, 2022

Presentation TVT 2022

TVARC Safety and Efficacy Endpoint Recommended for Clinical Trials

Presenter: Mahesh V. Madhavan

June 10, 2022

Presentation TVT 2022

Quality-of-life Assessments and Cost-effectiveness Analyses in TTVI Trials

Presenter: Geraldine Ong, Gilbert H. L. Tang, Yan Topilsky

June 10, 2022

Presentation TVT 2022

TV Replacement Will Win: Ease of Use and TR Reduction Are Key!

Presenter: Rebecca T. Hahn

June 10, 2022

Advertisement

Aortic Valve Disease Particularly Challenging to Manage Before Age 65: Review

Will Tricuspid Innovation Outpace Mitral? Some Hopes, Some Second-Guessing

Tricuspid Regurgitation After AF Diagnosis Is Common, Worsens Outcomes

COAPT Risk Score Useful in Predicting Outcomes in Functional MR

Assessment of Technical Success of T-TEER: Knowing When to Stop!

Defining the Anatomic and Clinical Boundaries of T-TEER: When Not to Do It!

TEE Guidance During T-TEER: Imaging Optimization and When to Pull the ICE Catheter!

Clinical Trial Data Supporting the Use of Tricuspid TEER in Symptomatic Severe TR Patients

A Left Ventricular Transcatheter Repair Device for HFrEF (Cardiac Success Vsling)

Combining the Best of Tricuspid Valve Repair & Replacement (CroiValve)

To Repair or Replace: A Treatment Algorithm Derived from Multimodality Imaging

TRILUMINATE Pivotal Trial: First Data Support Safety, Efficacy of TriClip

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

REPAIR MR: Expanding the Therapy Options for Moderate Risk DMR Patients with MitraClip

FDA Approves Pascal TEER Device for Degenerative MR

Radiation Exposure ‘Extraordinarily’ High for Imagers in Structural Procedures

Minorities, Poorer Patients Missing Out on Structural Heart Care

TVARC Safety and Efficacy Endpoint Recommended for Clinical Trials

Quality-of-life Assessments and Cost-effectiveness Analyses in TTVI Trials

TV Replacement Will Win: Ease of Use and TR Reduction Are Key!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content